Paul A. Bleicher, M.D., Ph.D., serves as a Chief Medical Officer and Director of Humedica, a next-generation clinica linformatics company that provides novel software-as-a-service (SaaS)-based business intelligence solutions to the health care and life sciences industries. Prior to Humedica, he was a director of Phase Forward, which he co-founded and helped grow from initial concept to its position as a leading provider of clinical trial data management and drug safety software. From its founding in 1997 until November 2008, Dr. Bleicher served as Chairman and held various leadership and executive roles, most recently that of Chief Strategy Officer. In November 2008, Dr. Bleicher stepped down from his day-to-day executive role at Phase Forward to join the founding team of the aforementioned Humedica. Dr. Bleicher earned his B.S. from Rensselaer Polytechnic Institute, and his M.D. and Ph.D., specializing in cellular immunology, from the University of Rochester School of Medicine and Dentistry. He previously worked at PAREXEL International, where he created and headed the Early Phase Services Department, assisting pharmaceutical and biotechnology companies with the initial development of novel therapies. Dr. Bleicher speaks and writes extensively about the role of technology, electronic data capture, and data visualization in the healthcare and pharmaceutical industry. In 1995, he chaired the first conference ever held in the pharmaceutical industry on the use of the Internet in drug development. Dr. Bleicher serves on the editorial boards of Applied Clinical Trials, Drug Information Journal, and Research Practitioner.In 2002, Dr. Bleicher won the Ernst and Young Entrepreneur of the Year Award in New England and was subsequently appointed to the Ernst and Young Entrepreneur’s Hall of Fame. In 2005, he was recognized by PharmaVoice as one of the 100 most inspiring people in the life sciences industry, and in 2006 he was awarded Boston Business Journal’s prestigious Champions in Health Care award. In 2007, he joined the Massachusetts Life Sciences Collaborative Leadership Council. Dr. Bleicher holds several issued patents in the U.S. and worldwide for a stem cell mobilizing biologic and for software design.
